Exact Sciences, US30063P1057

Exact Sciences stock heads into the open after a 1.8 percent dip

Published on 09/15/2026 at 08:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 11, 2026, Exact Sciences stock finished at USD 66.40 on the Nasdaq, down 1.8 percent, after trading between roughly USD 65.10 and USD 67.20. The move came as broader US equities saw mixed performance into the end of the week.

Wissenschaftlerinnen analysieren Krebsproben in einem modernen Diagnostiklabor von Exact Sciences
Exact Sciences Corp. betreibt hochmoderne Labore für die molekulare Krebsfrüherkennung weltweit ISIN US30063P1057, Illustration mit AI erstellt.

Exact Sciences stock closed at USD 66.40 on the Nasdaq on September 11, 2026, marking a decline of about 1.8 percent from the prior session. The shares traded in a range near USD 65.10 at the intraday low to around USD 67.20 at the high, leaving the price comfortably within its recent 52-week band, according to data summarized by Ad-hoc-news on September 14, 2026. Compared with major US indexes, the stock underperformed a generally mixed broader market into the end of that week, with large-cap benchmarks showing more muted moves.

September 11, 2026 in numbers

Exact Sciences Inc. (ISIN US30063P1057) saw its shares fluctuate between an intraday low near USD 65.10 and a high of roughly USD 67.20 before settling at USD 66.40 on September 11, 2026, per Nasdaq closing data cited by Ad-hoc-news. The approximately 1.8 percent drop on the day suggested a modest pullback, but the closing level remained well within the established 52-week range that has framed trading in recent months. While specific sector drivers were not highlighted, the stock's move contrasted with a mixed performance across major US indexes around that time, as technology and growth names experienced varying degrees of pressure following recent gains.

Outlook for today

Today, ahead of the US opening bell on September 15, 2026, investors will watch Exact Sciences stock in the context of upcoming central bank decisions and economic data that could influence sentiment toward higher-growth and healthcare-related names. Broader US equity futures were recently indicated near flat as traders looked toward the Federal Reserve's policy decision later this week and monitored developments in interest rates and commodity prices, according to coverage from CNBC on September 14, 2026. In the absence of a company-specific catalyst dated today in public calendars or recent filings, the shares are likely to be sensitive to shifts in the overall market tone and sector rotation patterns as the new session begins.

Disclaimer...

en | US30063P1057 | EXACT SCIENCES | boerse | 70104036 | bgmi